Agilent showcases solutions and partnerships transforming cancer research and therapeutics at aacr 2025

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) announced today its participation at the american association for cancer research (aacr) annual meeting on april 25-30, 2025 in chicago, illinois. innovative agilent products and partnerships playing a crucial role in transforming cancer research, diagnostics, and therapeutics will be featured, including: agilent avida dna cancer panels – based on cutting-edge next-generation sequencing (ngs) target enrichment solutions t.
A Ratings Summary
A Quant Ranking